Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,606 | 215 | 91.8% |
| Consulting Fee | $200.00 | 1 | 5.1% |
| Education | $121.77 | 24 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $858.06 | 53 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $615.15 | 29 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $379.14 | 14 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $378.93 | 13 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $370.88 | 39 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $255.35 | 20 | $0 (2023) |
| PFIZER INC. | $245.53 | 18 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $181.82 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $171.73 | 9 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $161.41 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.34 | 2 | Masimo Corporation ($14.32) |
| 2023 | $1,177 | 58 | Bayer Healthcare Pharmaceuticals Inc. ($216.11) |
| 2022 | $1,700 | 117 | Actelion Pharmaceuticals US, Inc. ($345.78) |
| 2021 | $1,033 | 63 | United Therapeutics Corporation ($382.17) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | Masimo Corporation | SedLine (Device) | Food and Beverage | Cash or cash equivalent | $14.32 | General |
| Category: Devices | ||||||
| 01/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $3.02 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/27/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Cardio-pulmonary | ||||||
| 10/16/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Cardiovascular | ||||||
| 10/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/29/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/22/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.08 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/22/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.65 | General |
| Category: Cardiovascular | ||||||
| 09/13/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.77 | General |
| Category: Cardiovascular | ||||||
| 09/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: DIABETES | ||||||
| 08/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Cardiology | ||||||
| 08/25/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Cardiology | ||||||
| 08/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: PAH | ||||||
| 08/17/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.14 | General |
| Category: Cardiovascular | ||||||
| 08/15/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/11/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Cardiovascular | ||||||
| 08/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $10.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/03/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/27/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: PAH | ||||||
| 07/25/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 417 | 711 | $141,909 | $45,971 |
| 2022 | 8 | 430 | 768 | $161,205 | $51,528 |
| 2021 | 12 | 617 | 1,198 | $226,914 | $76,078 |
| 2020 | 10 | 744 | 1,330 | $248,136 | $68,422 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 508 | $119,335 | $38,687 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 31 | $5,360 | $1,774 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,514 | $1,746 | 31.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 21 | 24 | $2,790 | $1,207 | 43.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,954 | $869.20 | 29.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 20 | 40 | $1,280 | $648.80 | 50.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 26 | 28 | $2,324 | $530.16 | 22.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 40 | $2,000 | $331.40 | 16.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $352.00 | $178.20 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 269 | 590 | $136,880 | $44,611 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $13,209 | $4,124 | 31.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 23 | $4,094 | $1,091 | 26.6% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 23 | 27 | $3,429 | $668.98 | 19.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 13 | 14 | $770.00 | $518.69 | 67.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 14 | 15 | $1,245 | $289.98 | 23.3% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 46 | 48 | $1,200 | $182.65 | 15.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 14 | $378.00 | $41.67 | 11.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 287 | 760 | $176,320 | $60,104 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 84 | $15,540 | $4,979 | 32.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $13,209 | $4,116 | 31.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 21 | $2,793 | $1,836 | 65.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 25 | 28 | $2,548 | $1,540 | 60.4% |
| 96374 | Injection of drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 24 | 50 | $6,350 | $1,276 | 20.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 42 | 43 | $3,569 | $944.58 | 26.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 13 | 14 | $770.00 | $526.68 | 68.4% |
About Alison Cieszko, PA-C
Alison Cieszko, PA-C is a Physician Assistant healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952387771.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alison Cieszko, PA-C has received a total of $3,928 in payments from pharmaceutical and medical device companies, with $17.34 received in 2024. These payments were reported across 240 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,606).
As a Medicare-enrolled provider, Cieszko has provided services to 2,208 Medicare beneficiaries, totaling 4,007 services with total Medicare billing of $242,000. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Greenville, NC
- Active Since 12/22/2005
- Last Updated 02/06/2026
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1952387771
Products in Payments
- TYVASO (Drug) $566.97
- ELIQUIS (Drug) $451.46
- OPSUMIT (Drug) $418.53
- Adempas (Drug) $244.07
- FARXIGA (Drug) $227.43
- UPTRAVI (Drug) $196.62
- LifeVest (Device) $181.82
- JARDIANCE (Drug) $171.73
- ENTRESTO (Drug) $162.59
- XARELTO (Drug) $161.41
- ORENITRAM (Drug) $154.19
- BRILINTA (Drug) $151.71
- CAMZYOS (Drug) $142.35
- Verquvo (Drug) $134.86
- Repatha (Biological) $126.99
- REMODULIN (Drug) $118.01
- LEQVIO (Drug) $92.76
- ONPATTRO (Drug) $65.41
- Barostim Neo System (Device) $48.45
- CardioMEMS HF System (Device) $36.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Greenville
Natalie Stapleton, Pa-C, PA-C
Physician Assistant — Payments: $10,941
Joshua Tucker, Pa-C, PA-C
Physician Assistant — Payments: $8,735
Dr. Kimberly Cowart, Dms, Pa-C, DMS, PA-C
Physician Assistant — Payments: $8,184
Hannah Heusing, Pa-C, PA-C
Physician Assistant — Payments: $8,032
Mr. Jack Sizemore, Pa, PA
Physician Assistant — Payments: $7,354
Ms. Jenifer Peters, P.a, P.A
Physician Assistant — Payments: $6,808